Market research
000538.SHE Yunnan Baiyao Group Co.,Ltd
SHE CNY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 93B
- P/E ratio
- 17.95
- Analyst target
- 67.855
- Dividend yield
- 3.0%
- Beta
- 0.12
Profile
Instrument facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CNE0000008X7
- Market cap
- 93B
- P/E ratio
- 17.95
- Analyst target
- 67.855
- Dividend yield
- 3.0%
- Beta
- 0.12
About
About Yunnan Baiyao Group Co.,Ltd
Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.
Research context
Yunnan Baiyao Group Co.,Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 000538.SHE discussion.
5 years, 6 months ago
Yunnan Baiyao Group Co.,Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Yunnan Baiyao Group Co.,Ltd's total revenue rose by 9.9% to $9B since the same quarter in the previous year.
Its net income has increased by 96.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 89.2% to $192M since the same quarter in the previous year.
Based on the above factors, Yunnan Baiyao Group Co.,Ltd gets an overall score of 3/5.